CRBP – corbus pharmaceuticals holdings, inc. (US:NASDAQ)
Stock Stats
News
3/12
12:08 pm
crbp
Low
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
3/12
08:05 am
crbp
Low
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock, down previously from $75.00.
3/11
03:17 pm
crbp
Low
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its price target lowered by analysts at Jefferies Financial Group Inc. from $70.00 to $53.00. They now have a "buy" rating on the stock.
3/11
08:06 am
crbp
Medium
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update [Yahoo! Finance]
3/11
08:00 am
crbp
Low
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
3/11/2025
08:00 am
crbp
-2.1%
BEAT
3/11/2025
08:00 am
crbp
-2.1%
BEAT
3/11/2025
08:00 am
crbp
3.1%
BEAT
3/11/2025
08:00 am
crbp
3.1%
BEAT
3/12
12:08 pm
Reiterates
Outperform
Wedbush
Low
1.6%
3/12
12:08 pm
Reiterates
Outperform
Wedbush
Low
1.6%
3/12
08:05 am
Reiterates
Buy
Buy
HC Wainwright
Low
1.3%
3/11
03:11 pm
Maintains
Buy
Buy
Jefferies
Low
-0.9%
3/11
03:11 pm
Maintains
Buy
Buy
Jefferies
Low
-0.9%
3/11
05:24 pm
crbp
Low
Form 10-K Corbus Pharmaceuticals For: Dec 31
3/11
08:30 am
crbp
Medium
Form 8-K Corbus Pharmaceuticals For: Mar 11
3/7
04:30 pm
crbp
Low
Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Smethurst Dominic
3/6
04:03 pm
crbp
Low
Form 144 Corbus Pharmaceuticals Filed by: Smethurst Dominic
2/18
05:41 pm
crbp
Medium
Form 4 Corbus Pharmaceuticals For: Feb 14 Filed by: Moran Sean F.
Show more
Top News Gainers
3/16 Form 10-K Corbus Pharmaceuticals For: Dec 31 23.8%
3/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) is now covered by analysts at Nomura. They set a "buy" rating and a $112.00 price target on the stock. 12.7%
3/12 Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2019 Earnings Call Transcript [The Motley Fool] 11.8%
3/18 Form 4 Corbus Pharmaceuticals For: Mar 17 Filed by: Millian Craig Stuart 10.0%
3/9 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Moran Sean F. 9.6%
3/18 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 9.3%
4/9 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.7%
5/10 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock. 5.2%
3/28 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.0%
1/14 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.8%
Top News Decliners
12/9 Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System -9.1%
5/9 Q1/2019 3/31/2019 EPS -0.430 ZacksConsensus 0.020 ActVsEst (0.450) - Miss -8.9%
8/8 Form 8-K Corbus Pharmaceuticals For: Aug 08 -8.7%
2/26 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.75 price target on the stock. -8.5%
11/7 Q3/2019 9/30/2019 EPS -0.320 ZacksConsensus -0.360 ActVsEst 0.040 - Beat -8.0%
3/12 Q4/2019 12/31/2019 EPS -0.410 ZacksConsensus -0.340 ActVsEst (0.070) - Miss -7.3%
3/10 Form 4 Corbus Pharmaceuticals For: Mar 06 Filed by: Salzmann Peter -6.8%
2/6 Corbus Pharmaceuticals Announces Proposed Public Offering of Common Stock -6.4%
8/13 Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $7.00 price target on the stock. -6.2%
3/5 Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020 -6.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3